100 Years of individual radiosensitivity: How we have forgotten the evidence

Radiology

Volumn 264, Issue 3, 2012, Pages 627-631

  Foray, Nicolas ^a   Colin, Catherine ^b   Bourguignon, Michel ^c  

^a INSERM   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c Autorite de Surete Nucleaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN;

ATAXIA TELANGIECTASIA; ATM GENE; BCRA1 GENE; BCRA2 GENE; BURN; BYSTANDER EFFECT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; DNA DAMAGE; DOSIMETRY; EDITORIAL; FAMILIAL CANCER; GENE; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTRICHOSIS; IONIZING RADIATION; LIG4 GENE; P53 GENE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INDUCED NEOPLASM; RADIATION PROTECTION; RADIOSENSITIVITY; X RAY;

CHROMOSOME ABERRATIONS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; HISTORY, 20TH CENTURY; HUMANS; MUTATION; NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PROTECTION; RADIATION TOLERANCE; SOCIETIES, MEDICAL;

EID: 84865416156     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112560     Document Type: Editorial

References (57)

1. Schiff E, Freund L. Contribution à l'étude de la radiothérapie. Ann Electrobiologie 1898;1:468-482.
2. Bouchacourt ML. Sur la différence de sensibilitéaux rayons de Roentgen de la peau des différents sujets, et, sur le même sujet des différents régions du corps. Proceedings of the 40th Congress of the French Association for the Advancement of Science, Lyon, France, 1911. Paris, France: Masson, 1911; 942-947.
3. Despeignes V. Observation concernant un cas de cancer de l'estomac traité par les rayons Roentgen. In: Lyon medical. Lyon, France: Librairie Médicale de Louis Savy, 1896; July 26, 428-430 and 503-506.
4. Serwer DP. The rise of radiation protection: science, medicine and technology in society, 1896-1935. Princeton, NJ: Princeton University, 1976.
5. Bergonié J, Tribondeau L. Interprétation de quelques résultats de la radiothérapie et essai de fixation d'une technique rationnelle. CR Acad Sci 1906;143:983-984.
6. Bordier G. Une nouvelle unité de quantitéde rayons X: l'unité I. Discussions. Proceedings of the 35th Congress of the French Association for the Advancement of Science, Lyon, France, 1906. Paris, France: Masson, 1906.
7. Regaud C, Lacassagne A. Effets histophysiologiques des rayons de Roentgen et de Becquerel-Curie sur les tissus adultes normaux des animaux supérieurs. In: Regaud C, ed. Radiophysiologie et radiothérapie. Paris, France: Presses Universitaires de France, 1927.
8. Laquerrière A. De la nécessité médico- légale de n'être pas trop affirmatif sur la pseudo-innocuité de certaines doses en radiothérapie. Arch Electricité Médicale 1907;15:604.
9. Arcelin M. Existe-t-il en radiothérapie des idiosyncrasies spontanées ou acquises. Arch Electricité Médicale 1911;19:37-61.
10. Clarke RH, Valentin J. The history of ICRP and the evolution of its policies. Ann ICRP 2009;39(1):75-110.
11. Puck TT, Marcus PI. Action of x-rays on mammalian cells. J Exp Med 1956;103(5): 653-666.
12. Fertil B, Malaise EP. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys 1981;7(5):621-629.
13. Fenech M, Holland N, Zeiger E, et al. The HUMN and HUMNxL international collaboration projects on human micronucleus assays in lymphocytes and buccal cells: past, present and future. Mutagenesis 2011;26(1):239-245.
14. Pantelias GE, Terzoudi GI. A standardized G2-assay for the prediction of individual radiosensitivity. Radiother Oncol 2011;101(1):28-34.
15. Chua ML, Somaiah N, Bourne S, et al. Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. Radiother Oncol 2011;99(2):225-230.
16. Joubert A, Gamo K, Bencokova Z, et al. DNA double-strand break repair defects in syndromes associated with acute radiation response: at least two different assays to predict intrinsic radiosensitivity? Int J Radiat Biol 2008;84(2):107-125.
17. Massart C, Joubert A, Granzotto A, et al. Prediction of the human radiosensitivity: what is the most relevant endpoint? gene expressions, mutations or functions? In: Hauppauge NY, ed. Genotoxicity, testing and prediction. New York, NY: Nova Science Publishers, 2009.
18. Rothkamm K, Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 2003;100(9):5057-5062.
19. Badie C, Iliakis G, Foray N, et al. Induction and rejoining of DNA double-strand breaks and interphase chromosome breaks after exposure to x rays in one normal and two hypersensitive human fibroblast cell lines. Radiat Res 1995;144(1):26-35.
20. Foray N, Priestley A, Alsbeih G, et al. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol 1997;72(3):271-283.
21. Attard-Montalto SP, Saha V, Kingston J, et al. Increased radiosensitivity in a child with T-cell non-Hodgkin's lymphoma. Med Pediatr Oncol 1996;27(6):564-570.
22. Plowman PN, Bridges BA, Arlett CF, Hinney A, Kingston JE. An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. Br J Radiol 1990;63(752):624-628.
23. Pietrucha BM, Heropolitańska-Pliszka E, Wakulińska A, Skopczyńska H, Gatti RA, Bernatowska E. Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation. J Pediatr Hematol Oncol 2010;32(1):e28-e30.
24. Concannon P, Gatti RA. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat 1997;10(2):100-107.
25. Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 1996;34(1):251-266.
26. Micol R, Ben Slama L, Suarez F, et al. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol 2011;128(2):382-389.
27. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91(15): 1310-1316.
28. Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G, Feunteun J. Gammarays- induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 1999;18(51):7334-7342.
29. Ramus SJ, Antoniou AC, Kuchenbaecker KB, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat 2012;33(4):690-702.
30. Thompson D, Easton DF; Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94(18):1358-1365.
31. Wang F, Fang Q, Ge Z, Yu N, Xu S, Fan X. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review. Mol Biol Rep 2012;39(3):2109-2118.
32. Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer 2012;118(5):1387-1396.
33. Milne RL. Variants in the ATM gene and breast cancer susceptibility. Genome Med 2009;1(1):12.
34. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991;325(26):1831-1836.
35. Feight D, Baney T, Bruce S, McQuestion M. Putting evidence into practice. Clin J Oncol Nurs 2011;15(5):481-492.
36. Schnur JB, Love B, Scheckner BL, Green S, Wernicke AG, Montgomery GH. A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. Am J Clin Oncol 2011;34(5):529-536.
37. DahlBerg WK, Little JB. Response of dermal fibroblast cultures from patients with unusually severe responses to radiotherapy and from ataxia telangiectasia heterozygotes to fractionated radiation. Clin Cancer Res 1995;1(8):785-790.
38. Jung H, Beck-Bornholdt HP, Svoboda V, Alberti W, Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol 2001;61(3):233-246.
39. Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001;61(3):223-231.
40. Ash D. Lessons from Epinal. Clin Oncol (R Coll Radiol) 2007;19(8):614-615.
41. Tutt A, Ashworth A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med 2002;8(12):571-576.
42. Löbrich M, Jeggo PA. The two edges of the ATM sword: co-operation between repair and checkpoint functions. Radiother Oncol 2005;76(2):112-118.
43. Zschenker O, Raabe A, Boeckelmann IK, et al. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol 2010;97(1):26-32.
44. Chan DW, Gately DP, Urban S, et al. Lack of correlation between ATM protein expression and tumour cell radiosensitivity. Int J Radiat Biol 1998;74(2):217-224.
45. Bernstein JL, Haile RW, Stovall M, et al. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst 2010;102(7):475-483.
46. Brenner DJ. Contralateral second breast cancers: prediction and prevention. J Natl Cancer Inst 2010;102(7):444-445.
47. John EM, Phipps AI, Knight JA, et al. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer 2007;121(2): 386-394.
48. Iliakis G. The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. Bioessays 1991;13(12): 641-648.
49. Foray N, Arlett CF, Malaise EP. Radiation-induced DNA double-strand breaks and the radiosensitivity of human cells: a closer look. Biochimie 1997;79(9-10):567-575.
50. Colin C, Devic C, Noël A, et al. DNA double-strand breaks induced by mammographic screening procedures in human mammary epithelial cells. Int J Radiat Biol 2011;87(11):1103-1112.
51. Colin C, Granzotto A, Devic C, et al. MRE11 and H2AX biomarkers in the response to low-dose exposure: Balance between individual susceptibility to radiosensitivity and to genomic instability. Int J Low Radiat 2011;2:96-106.
52. Słonina D, Biesaga B, Urbański K, Kojs Z. The response of primary keratinocytes and fibroblasts from cancer patients to multiple low-dose irradiations. Radiat Res 2007;168(5):631-636.
53. Słonina D, Biesaga B, Urbański K, Kojs Z. Low-dose radiation response of primary keratinocytes and fibroblasts from patients with cervix cancer. Radiat Res 2007;167(3):251-259.
54. Colin C, Foray N. DNA damage induced by mammography in high family risk patients: only one single view in screening. Breast. PMID 22212747. Published December 31, 2011. Accessed 2012.
55. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151(10):727- 737, W237-W242.
56. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007;37(2-4):1-332.
57. Valentin J. Low-dose extrapolation of radiation-related cancer risk. Ann ICRP 2005;35(4):1-140.